The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of large language models on trial-to-patient matching efficiency.
 
Nathan Rich
Honoraria - Aptitude Health; Caris Life Sciences; Cornerstone; MDoutlook
Consulting or Advisory Role - Tempus
 
Sarah Salzman
No Relationships to Disclose
 
Gabriel Altay
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Kunal Nagpal
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Vivek Shetye
Employment - Tempus AI, Inc
 
Gena Rangel
No Relationships to Disclose
 
Poojan Thakkar
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Annie Darmofal
Employment - Tempus AI, Inc
Stock and Other Ownership Interests - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Dan Sun
Employment - Tempus AI, Inc
Stock and Other Ownership Interests - Tempus AI, Inc
 
Bert O'Neil
Consulting or Advisory Role - Amgen
Speakers' Bureau - AstraZeneca
 
Ahmad Zarzour
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
 
John Nemunaitis
Employment - Gradalis
 
James Maher
Consulting or Advisory Role - Tempus
 
Philip Lammers
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb/Sanofi; Daiichi Sankyo/Astra Zeneca; Genzyme; Merck; Pfizer; Puma Biotechnology; Tempus; Teva
Speakers' Bureau - Amgen; AstraZeneca
 
Srilata Gundala
No Relationships to Disclose
 
Timothy Pluard
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Carrick Therapeutics; Daiichi Sankyo/Astra Zeneca; DualityBio; Gilead Sciences; Jazz Pharmaceuticals; Kestrel Therapeutics; Merck; Novartis; Pfizer; Scorpion Therapeutics; Seagen; Sermonix Pharmaceuticals; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; SeaGen; Stemline Therapeutics
Research Funding - Arvinas; AstraZeneca/Daiichi Sankyo (Inst); Dantari (Inst); G1 Therapeutics (Inst); H3 Biomedicine (Inst); HiberCell (Inst); Novartis; Novartis; Olema Pharmaceuticals (Inst); Orinove (Inst); Pfizer (Inst); Sanofi (Inst); Scorpion Therapeutics; Seagen (Inst); Zymeworks (Inst)
 
Viran Holden
Employment - American Oncology Partners, PA
Research Funding - Abbvie; Amgen; BeiGene; Boehringer Ingelheim; Caidya; Medimergent; Roche/Genentech; Tempus
 
Arpita Saha
Employment - Cymabay Therapeutics (I); Tempus
Stock and Other Ownership Interests - Cymabay Therapeutics (I); Nurix (I); Summit Therapeutics (I); Tempus
Patents, Royalties, Other Intellectual Property - 18/679,338 GenAI - Agent Use Cases SYSTEMS AND METHODS FOR DEPLOYING A MACHINE-LEARNING MODEL FOR PERFORMING A SPECIFIC CLINICAL TASK; 63/712,334 Digital specialist - Patient Explorer SYSTEMS AND METHODS OF STRUCTURING AND QUERYING SUBJECT DATA; PCT/US24/31756 GenAI - PCT Omnibus SYSTEMS AND METHODS FOR GENERATING AND DEPLOYING TASK-SPECIFIC AGENTS
Travel, Accommodations, Expenses - Tempus
 
Victoria Chiou
Employment - AstraZeneca; Tempus AI, Inc.
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca; Tempus AI, Inc.
Travel, Accommodations, Expenses - AstraZeneca; Tempus AI, Inc.
 
Chelsea Osterman
Employment - Flatiron Health; Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.